Dr Ooi Xue Ting is an Associate Consultant with the National University Health System, practising across National University Hospital and Ng Teng Fong General Hospital. She provides comprehensive care for patients with a wide range of skin, hair, and nail conditions, with subspecialty interests in immunodermatology, paediatric dermatology, and hidradenitis suppurativa.
Dr Ooi graduated from the Yong Loo Lin School of Medicine in 2017. She went on to obtain both the Membership of the Royal College of Physicians (MRCP, UK) and Master of Internal Medicine (Singapore) qualifications in 2019. She completed her Internal Medicine Residency training at National University Hospital in 2021 before pursuing specialist training under the National Healthcare Group Dermatology Residency Programme. In 2025, she received Dermatology specialist accreditation from the Specialist Accreditation Board of Singapore.
In addition to managing general dermatological conditions, Dr Ooi is actively involved in multidisciplinary and subspecialty dermatology care. She is committed to delivering patient-centred, evidence-based treatment tailored to each individual’s needs.
Dr Ooi is also passionate about medical education and mentorship. She serves as a Core Faculty member of the Postgraduate Year 1 Residency Programme for the Department of Medicine at National University Health System, and regularly teaches Internal Medicine and Family Medicine residents.
1. Ooi, X. T., Tan, K. B., & Chandran, N. (2019). A case of pediatric rosacea-Skin and ocular involvement. Clinical case reports, 7(12), 2414–2416.
2. Xue Ting, O., May, L. M., Jingxiang, H., & Huma, J. (2020). A case of exemestane induced pseudocellulitis. Dermatologic therapy, 33(4), e13428.
3. Koh, X. Q., Ooi, X. T., Sun, Y., Chandran, N. S., & Tan, C. L. (2020). A retrospective analysis of dermatological problems in haematology and oncology patients at a tertiary Singapore hospital. The Australasian journal of dermatology, 61(4), e474–e476.
4. Choi, E., Ooi, X. T., & Chandran, N. S. (2022). Hidradenitis suppurativa in pediatric patients. Journal of the American Academy of Dermatology, 86(1), 140–147.
5. Ooi, X. T., Choi, E. C., & Lee, J. S. (2022). Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine. International journal of dermatology, 61(11), 1425–1426.
6. Choi, E., Mir, S. A., Ji, S., Ooi, X. T., Chua, E. W. L., Yi Wei, Y., Wenk, M. R., Bendt, A. K., & Chandran, N. S. (2022). Understanding the systemic burden of disease in hidradenitis suppurativa from plasma lipidomic analysis. Journal of dermatological science, 107(3), 133–141.
7. Ooi, X. T., Choi, E., Han, H., Ahmad, H., Patwardhan, K. R., & Chandran, N. S. (2022). The psychosocial burden of hidradenitis suppurativa in Singapore. JAAD international, 10, 89–94.
8. Wang, H. X. E., Ooi, X. T., Lim, K. H., & Oh, C. C. (2023). Rapidly progressing necrotic hand ulcer in a patient with angioimmunoblastic T-cell lymphoma. Skin health and disease, 3(4), e236.
9. Boey, Jonathan Yongwei, Ooi, Xue Ting, Kuan, Amanda, Chuah, Sai Yee, Jhingan, Anjali, Vardy, Leah A., Thng, Steven, Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-Blinded, Split-Face–Controlled Pilot Trial, Dermatologic Therapy, 2026, 8828628, 8 pages, 2026.
